Related Experiment Video
Updated: Jun 1, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
[ABCA1 gene expression in peripheral blood lymphocytes and macrophages in patients with atherosclerosis]
Insights
This study reveals reduced ABCA1 transporter mRNA in leukocytes but increased levels in macrophages of atherosclerosis patients. These findings suggest ABCA1 gene expression impacts atherosclerosis development.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Genetics
Background:
- The ATP-binding cassette transporter A1 (ABCA1) is crucial for cholesterol efflux from peripheral tissues.
- The precise role of ABCA1 in the pathogenesis of atherosclerosis requires further elucidation.
Purpose of the Study:
- To investigate the expression levels of ABCA1 mRNA in leukocytes and macrophages of patients with atherosclerosis compared to healthy controls.
- To determine the potential contribution of ABCA1 gene expression to atherosclerosis development.
Main Methods:
- Real-Time quantitative Polymerase Chain Reaction (RT-PCR) was employed to measure ABCA1 mRNA levels.
- Leukocytes and macrophages were isolated from patients diagnosed with atherosclerosis and from control individuals.
Main Results:
- A statistically significant reduction in ABCA1 mRNA levels was observed in the leukocytes of atherosclerosis patients (0.57 +/- 0.28) compared to controls (0.93 +/- 0.14, p = 0.02).
- Conversely, a significant increase in ABCA1 mRNA levels was detected in the macrophages of patients (1.32 +/- 0.10) relative to controls (0.90 +/- 0.14, p = 0.014).
Conclusions:
- The differential expression of ABCA1 mRNA in leukocytes and macrophages suggests a complex role in atherosclerosis.
- ABCA1 gene expression patterns may be a contributing factor in the development and progression of atherosclerosis.
Abstract:
ABCA1 transporter is known to play important role in the cholesterol transport from peripheral tissues. However its contribution in atherosclerosis development remains not completely understood. Using Real Time PCR, a significant reduction of ABCA1 mRNA level in leukocytes of patients with atherosclerosis was determined when compared with controls. Mean ABCA1 expression levels in leukocytes for the group of patients and for the control group are 0.57 +/- 0.28 and 0.93 +/- 0.14 (p = 0.02). At the same time we detected a significant increase of ABCA1 mRNA level in macrophages of patients when compared with controls. Mean ABCA1 expression levels in macrophages for the group of patients and for the control group are 1.32 +/- 0.10 and 0.90 +/- 0.14 (p = 0.014). In summary, we suggest that expression level of ABCA1 gene may contribute to the development of atherosclerosis.
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology
